Company & Sponsor Intelligence

University of Texas at Austin

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting3

Completed2

Countries1

Therapeutic footprint

anxietyautismdepressionepilepsystroke

Indexed studies

NCT06923553Implementation of Naturalistic Developmental Behavioral Intervention (NDBI) Through Coaching Caregivers of Young Autistic Children
autism · United StatesNA

NCT00005420Prediction of Quality of Life in Cardiovascular Disease
stroke · COMPLETED

NCT01818453Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression?
depression · United StatesNA

NCT05307094Optimizing Intervention Options for Toddlers With Early Social Communication Delays
autism · United StatesNA

NCT06940089Invasive Brain-Computer Interfaces for Attention
epilepsy · United StatesNA

NCT06587594Supportive Outcomes Through Listening, Validation, and Empowerment
autism · United StatesNA

NCT04745260Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair
anxiety · NA

NCT07319234Development of MENU Protocol
autism · NA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →